检索规则说明:AND代表“并且”;OR代表“或者”;NOT代表“不包含”;(注意必须大写,运算符两边需空一格)
检 索 范 例 :范例一: (K=图书馆学 OR K=情报学) AND A=范并思 范例二:J=计算机应用与软件 AND (U=C++ OR U=Basic) NOT M=Visual
作 者:王春光[1] 刘蕊 韩宝君[3] 杜欣帅[4] 刘洋[5] 赵林 焦阳 WANG Chunguang;LIU Rui;HAN Baojun;DU Xinshuai;LIU Yang;ZHAO Lin;JIAO Yang(Department of Anesthesiology,the First Center Hospital of Baoding,Baoding 071000,China)
机构地区:[1]保定市第一中心医院麻醉科,071000 [2]承德医学院 [3]保定市第一中心医院骨科 [4]保定市第一中心医院超声科 [5]保定市第一中心医院医学影像科 [6]保定市第一中心医院手术室
出 处:《临床麻醉学杂志》2020年第12期1169-1172,共4页Journal of Clinical Anesthesiology
基 金:河北省医学科学研究课题计划项目(20191236);保定市科学研究与发展计划项目(16ZF070)。
摘 要:目的探讨复合右美托咪定对收肌管内隐神经阻滞罗哌卡因半数有效浓度(EC 50)的影响。方法择期行全膝关节置换术患者54例,男29例,女25例,年龄53~76岁,ASAⅠ或Ⅱ级,随机分为两组:对照组(C组)和右美托咪定组(D组)。C组仅应用罗哌卡因溶液行收肌管内隐神经阻滞;D组收肌管内隐神经阻滞用药为含右美托咪定1μg/kg的罗哌卡因混合溶液。采用序贯法确定罗哌卡因的浓度,初始浓度为0.5%,相邻浓度之比为1∶1.2,注药后30 min隐神经支配区域感觉阻滞完全为阳性反应,下一例患者则采用低一级的浓度,反之则采用高一级的浓度。应用概率单位法计算罗哌卡因用于收肌管内隐神经阻滞的EC 50及其95%可信区间(CI)。结果C组和D组罗哌卡因EC 50分别为0.38%(95%CI 0.36%~0.41%)和0.29%(95%CI 0.28%~0.31%),且D组明显低于C组(P<0.05)。结论复合右美托咪定1μg/kg可降低收肌管内隐神经阻滞罗哌卡因的EC 50。Objective To investigate the effect of combination of dexmedetomidine on the median effective concentration(EC 50)of ropivacaine for saphenous nerve block in adductor canal.Methods Fifty-four patients undergoing total knee arthroplasty,29 males and 25 females,aged 53-76 years,ASA physical statusⅠorⅡ,were divided into two groups:control group(group C)and dexmedetomidine group(group D).Saphenous nerve block in adductor canal was performed using only ropivacaine in group C.The mixture of ropivacaine and dexmedetomidine 1μg/kg was used for saphenous nerve block in adductor canal in group D.The EC 50 of ropivacaine was determined by up and down sequential trial.The initial concentration of ropivacaine was set at 0.5%,and the ratio between the two successive concentration was 1∶1.2.Each time the concentration increased or decreased in the next patient according to whether or not the sensory block was complete at 0.5 h after injected ropivacaine.The probability unit method was used to determine the EC 50 and 95%confidence interval(CI)of ropivacaine for saphenous nerve block in adductor canal.Results The EC 50 and 95%CI of ropivacaine for ultrasound-guided saphenous nerve block in adductor canal was 0.38%(95%CI 0.36%-0.41%)in group C and 0.29%(95%CI 0.28%-0.31%)in group D.The EC 50 of ropivacaine for ultrasound-guided saphenous nerve block in adductor canal was lower in group D than in group C(P<0.05).Conclusion The EC 50 of ropivacaine could be decreased by the combination of dexmedetomidine for saphenous nerve block in adductor canal.
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在链接到云南高校图书馆文献保障联盟下载...
云南高校图书馆联盟文献共享服务平台 版权所有©
您的IP:18.222.132.108